Clinical and laboratory predictors of survival in Gambian patients with symptomatic HIV-1 or HIV-2 infection
about
The Glutamine-rich Region of the HIV-1 Tat Protein Is Involved in T-cell ApoptosisProgression to symptomatic disease in people infected with HIV-1 in rural Uganda: prospective cohort studyComparing HIV-1 and HIV-2 infection: Lessons for viral immunopathogenesis.Modified Kigali combined staging predicts risk of mortality in HIV-infected adults in Lusaka, Zambia.Are plasma biomarkers of immune activation predictive of HIV progression: a longitudinal comparison and analyses in HIV-1 and HIV-2 infections?AIDS related eye disease in Burundi, AfricaClinical predictors cannot replace biological predictors in HIV-2 infection in a community setting in West AfricaRobust Gag-specific T cell responses characterize viremia control in HIV-2 infection.Polymorphism and drug-selected mutations in the protease gene of human immunodeficiency virus type 2 from patients living in Southern France.Genetic diversity of human immunodeficiency virus type 2: evidence for distinct sequence subtypes with differences in virus biologyTenets of protection from progression to AIDS: lessons from the immune responses to HIV-2 infection.Retinal findings in Malawian patients with AIDSThe epidemiology of CMV retinitis in Africa.Epidemiological characteristics of human immunodeficiency virus type-2 infection in Africa.Clinical features, immunological changes and mortality in a cohort of HIV-2-infected individuals in Bissau, Guinea-Bissau.Higher set point plasma viral load and more-severe acute HIV type 1 (HIV-1) illness predict mortality among high-risk HIV-1-infected African women.HIV progression and predictors of mortality in a community-based cohort of Zambian adults.An evaluation of low-cost progression markers in HIV-1 seropositive Zambians.
P2860
Q22248069-D5824E5C-DCFF-4B88-BDA9-F223A263A25BQ24555060-97A08299-F167-4727-BDA6-B26D9A9097F1Q34035802-79AFE5B8-7BAA-4BA7-B0ED-464BE843FA25Q34085355-8330F5A4-0B68-42CB-BD9E-C09A9EC96427Q34412376-4BD05AB1-2AE5-4F29-A86B-3272FC01693FQ35309267-5F96610F-FD33-4737-861F-73460CA5D869Q35884346-6DE629B6-AA46-41F4-B74F-35C0AEA1668BQ35970916-A7E86288-96DE-4D5C-8A28-20A2316126A8Q36239954-B6FDEBFA-AA24-4A4B-A727-61C2CE215DA6Q36637244-CC6C00A0-EFA8-4549-9DE4-BD3DCEAAF908Q37130458-B6DEF6C2-3186-4774-B4F0-D8EBE67950B8Q37308474-55F0498B-3EA7-437D-BD3C-2F2F524C2E6AQ45181827-59DB06BF-A52C-46C0-ADF8-BA67CC7614C7Q45785207-B5984312-9CBF-4D3A-B4D8-A1C258C21665Q46286195-D393EFC3-E52B-43EA-9500-8C03FB47C90FQ46695815-BB1E4FEC-3DF5-4D79-859B-56FA2134A089Q46909904-B4220B24-C350-4F20-9866-21DD515BA2ADQ46918946-D1AC1EF9-EDB9-4A64-B9C1-9E2F524FF69F
P2860
Clinical and laboratory predictors of survival in Gambian patients with symptomatic HIV-1 or HIV-2 infection
description
1992 nî lūn-bûn
@nan
1992 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
1992 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
1992年の論文
@ja
1992年論文
@yue
1992年論文
@zh-hant
1992年論文
@zh-hk
1992年論文
@zh-mo
1992年論文
@zh-tw
1992年论文
@wuu
name
Clinical and laboratory predic ...... matic HIV-1 or HIV-2 infection
@ast
Clinical and laboratory predic ...... matic HIV-1 or HIV-2 infection
@en
Clinical and laboratory predic ...... matic HIV-1 or HIV-2 infection
@nl
type
label
Clinical and laboratory predic ...... matic HIV-1 or HIV-2 infection
@ast
Clinical and laboratory predic ...... matic HIV-1 or HIV-2 infection
@en
Clinical and laboratory predic ...... matic HIV-1 or HIV-2 infection
@nl
prefLabel
Clinical and laboratory predic ...... matic HIV-1 or HIV-2 infection
@ast
Clinical and laboratory predic ...... matic HIV-1 or HIV-2 infection
@en
Clinical and laboratory predic ...... matic HIV-1 or HIV-2 infection
@nl
P2093
P1433
P1476
Clinical and laboratory predic ...... matic HIV-1 or HIV-2 infection
@en
P2093
P356
10.1097/00002030-199207000-00011
P407
P577
1992-07-01T00:00:00Z